Posted inGenetics
Antibodies Connect Cancer with Autoimmune Brain Disease
Credit: Love Employee/Getty Images The link between cancer and brain function, specifically emotion and motivation is well documented. The connection…
Posted inBiotechnology
Chutes & Ladders—Tang takes over Aurinia after FDA brouhaha
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Posted inGenetics
From Variability to Reliability: A New IgG4 Reference Standard for Consistent Characterization
Analytical developers and biomanufacturers working with immunoglobulin G4 (IgG4) monoclonal antibodies have long faced a critical gap: the absence of…
Posted inBiotechnology
Starburst Winds Drain Supernova Energy Quickly
In the depths of starburst galaxies, where intense star formation churns out new stars at prodigious rates, the powerful winds…
Posted inBiotechnology
Decoding the Phosphorus Puzzle: How Microplastics and Hydrochar Transform Nutrient Dynamics in Rice Paddies
Phosphorus is an elemental cornerstone of life on Earth, pivotal for the growth and development of plants, and consequently, for…
Posted inMedical Technology
CMR Surgical kicks off Versius Plus robot’s US commercial launch
Following FDA approval last December for its upgraded robot, CMR Surgical has begun rolling out its Versius Plus platform in…
Posted inGenetics
Georgia Chosen as the Location for UCB’s New U.S. Biologics Manufacturing Facility
Credit: Reptile8488/Getty Images Belgium-based UCB selected Gwinnett County, Georgia, as the location for its new U.S. biologics manufacturing facility. The…
Posted inMedical Technology
Philips AI cath lab copilot nets FDA clearance
Philips has secured an FDA clearance for its artificial intelligence program that tracks and guides the placement of a minimally…
Posted inBiotechnology
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Pulmatrix may have been discarded by Cullgen, but the inhaled therapy biotech’s Nasdaq listing has caught the attention of another…
Posted inBiotechnology
OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline
Oral peptide specialist Pinnacle Medicines has secured an $89 million series B with backing from investors in the U.S. and…